N

Nektar Therapeutics

640 employees

Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.

Investor insights

Sectors invested in

Immunology1
Medical1
Biotechnology1
Health Care1
Respiratory product development1
Infection1
Biologics1
Regulatory strategy1
Treatment and prevention of chronic respiratory diseases and asthma.1
High quality therapies for COPD and Asthma1
Inhaled therapeutics including MDIs and DPIs1

Funding rounds participated in

$18M sweet spot round size

Most of their 1 investments are in rounds between $18M and $18M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Chemical
Health Care
Therapeutics
Drug Development and Polymer Conjugate Chemistry

Date founded

1990

Investments made

P

Pearl Therapeutics raised $18M on July 3, 2008

Investors: New Leaf Venture Partners, Clarus Ventures, LLC, 5AM Ventures and Nektar Therapeutics

Funding rounds raised

Total raised

$150M

from 1 investors over 1 rounds

N

Nektar Therapeutics raised $150M on February 17, 2021

Investors: SFJ Pharmaceuticals, Inc.

FAQ